Welcome to LookChem.com Sign In|Join Free
  • or
5-[(4-benzylphenoxy)methyl]-N'-(1,3,4-trimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)-2-furohydrazide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

637012-54-5

Post Buying Request

637012-54-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

637012-54-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 637012-54-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,7,0,1 and 2 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 637012-54:
(8*6)+(7*3)+(6*7)+(5*0)+(4*1)+(3*2)+(2*5)+(1*4)=135
135 % 10 = 5
So 637012-54-5 is a valid CAS Registry Number.

637012-54-5Downstream Products

637012-54-5Relevant academic research and scientific papers

Non-peptide GnRH agents, pharmaceutical compositions and methods for their use

-

, (2008/06/13)

Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.

NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE

-

Page 29-30, (2010/02/06)

Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression o£ gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 637012-54-5